Literature DB >> 3001125

The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.

M Hotta, T Shibasaki, A Masuda, T Imaki, H Demura, N Ling, K Shizume.   

Abstract

Pituitary-adrenocortical responses to the iv injection of 100 micrograms synthetic ovine corticotropin-releasing hormone (CRH) were studied in 13 patients with anorexia nervosa, and the concentrations of immunoreactive CRH in cerebrospinal fluid were measured in 7 of them. Mean basal levels of plasma ACTH and cortisol were 32 +/- 5 pg/ml (+/- SEM) and 21.1 +/- 1.5 micrograms/dl, respectively. The latter value was significantly higher than that in age-matched normal women (P less than 0.005). The mean increments of plasma ACTH and cortisol in response to CRH injection in those 13 patients were 21 +/- 5 pg/ml and 5.3 +/- 1.7 micrograms/dl, respectively, significantly lower than those in normal women (58 +/- 6 pg/ml and 15.3 +/- 7.7 micrograms/dl, respectively; P less than 0.005). When 4 patients were reexamined after weight gains of between 3 and 22 kg, their responses to the CRH injection increased. The mean concentration of immunoreactive CRH in the cerebrospinal fluid of seven patients was 30.8 +/- 3.9 pg/ml (+/- SEM), which was higher than the value of 18.4 +/- 1.1 pg/ml (P less than 0.005) in control subjects with cervical spondylosis. These findings suggest the possibility that hypersecretion of CRH may occur in patients with anorexia nervosa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001125     DOI: 10.1210/jcem-62-2-319

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Predictors of menstrual resumption by patients with anorexia nervosa.

Authors:  C Arimura; T Nozaki; S Takakura; K Kawai; M Takii; N Sudo; C Kubo
Journal:  Eat Weight Disord       Date:  2010-05-10       Impact factor: 4.652

Review 2.  Appetite regulation: the role of peptides and hormones.

Authors:  J E Morley
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

Review 3.  Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

Authors:  M Nink; U Krause; H Lehnert; J Beyer
Journal:  Klin Wochenschr       Date:  1991-03-18

Review 4.  The neuroendocrine approach to psychiatric disorders: a critical appraisal.

Authors:  E E Müller
Journal:  J Neural Transm Gen Sect       Date:  1990

5.  Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.

Authors:  Marie M Onakomaiya; Donna M Porter; Joseph G Oberlander; Leslie P Henderson
Journal:  Horm Behav       Date:  2014-04-21       Impact factor: 3.587

Review 6.  Menstrual function and its relationship to stress, exercise, and body weight.

Authors:  P R Gindoff
Journal:  Bull N Y Acad Med       Date:  1989-09

7.  Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system.

Authors:  K R Melia; R S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.

Authors:  A Sasaki; O Shinkawa; K Yoshinaga
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

9.  The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa.

Authors:  F Lanfranco; L Gianotti; A Picu; S Fassino; G Abbate Daga; V Mondelli; R Giordano; S Grottoli; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

10.  Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion.

Authors:  A Masuda; T Shibasaki; M Hotta; H Suematsu; K Shizume
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.